Krystle G. Wang, MD
Dermatology · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 28
- 6 carriers
- Office
- 1
Offices
1 location · Golden State Dermatology Associates, Inc. · 118 clinicians in this group
Plans that list them
28 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wang’s office at (925) 932-7704 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
28 of 28 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A141215 · Current
Licensed to practise in California · since 2016 · expires 2027-07-31 · Jefferson Medical College of Thomas Jefferson University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Florida ME117991Medical Doctor · since 2013 · expires 2018-01-31Null And VoidNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
2 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- Jefferson Medical College of Thomas Jefferson University · MD2006–2010Medical school
Residency and fellowship
- Thomas Jefferson University Hospital, DermatologyPHILADELPHIA, PA · 2011–2014
- Lankenau Medical Center, Internal MedicineWYNNEWOOD, PA · 2010–2011
Original Medicare doctor bills
$283,187
Medicare paid this office $283,187 for 281 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 201 | $33,626 | $85 |
| Destruction of precancer skin growth, 1 growth | 133 | $15,576 | $63 |
| Return visit (30+ min) | 76 | $14,547 | $118 |
| Destruction of skin growth, 1-14 growths | 46 | $8,005 | $114 |
| Destruction of precancer skin growth, 2-14 growths | 112 | $7,638 | $7 |
See all 11 services
| Short return visit (20+ min) | 201 | $33,626 | $85 |
| Destruction of precancer skin growth, 1 growth | 133 | $15,576 | $63 |
| Return visit (30+ min) | 76 | $14,547 | $118 |
| Destruction of skin growth, 1-14 growths | 46 | $8,005 | $114 |
| Destruction of precancer skin growth, 2-14 growths | 112 | $7,638 | $7 |
| Biopsy of related skin growth, first growth | 35 | $3,998 | $103 |
| New patient visit (45+ min) | 11 | $1,652 | $150 |
| New patient visit (15+ min) | 27 | $1,619 | $60 |
| New patient visit (30+ min) | 16 | $1,552 | $97 |
| Pathology examination of tissue using a microscope, intermediate complexity | 16 | $654 | $36 |
| Injection of drug or substance under skin or into muscle | 11 | $496 | $15 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 13 | More than 67% of doctors who do this |
| Removal of nail tissue | 1-10 | None |
| Removal of skin lesions | 541 | More than 87% of doctors who do this |
| Skin biopsy | 67 | More than 72% of doctors who do this |
Who their Medicare patients are
281 Original Medicare patients in 2024. Average age 76 · Women 63% · Health risk score 0.99. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 68% · Coronary heart disease 23% · Diabetes 21% · Atrial fibrillation 19% · Chronic kidney disease 15% · Cancer 14% · Heart failure 12% · Depression 11% · COPD 7% · Dementia 6% · Stroke 6%.
The office billed $540,076, Medicare allowed $364,309 and paid $283,187; for 3,857 services of 37 kinds; $184,066 of it was for drugs given in the office and $99,121 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 281 | 3,857 | 76 | 0.99 | $540,076 | $283,187 |
| 2023 | 260 | 2,816 | 77 | 0.88 | $383,978 | $185,782 |
| 2022 | 205 | 2,000 | 76 | 0.93 | $269,260 | $141,655 |
| 2021 | 240 | 3,656 | 76 | 1.13 | $487,911 | $290,529 |
| 2020 | 205 | 1,549 | 77 | 1.00 | $206,046 | $93,158 |
| 2019 | 210 | 1,104 | 77 | 1.11 | $147,899 | $53,658 |
| 2018 | 214 | 999 | 78 | 1.27 | $146,228 | $55,864 |
| 2017 | 165 | 610 | 77 | 1.29 | $90,636 | $37,459 |
| 2016 | 168 | 633 | 74 | 1.09 | $79,005 | $36,435 |
| 2015 | 175 | 1,048 | 73 | 1.23 | $107,790 | $56,296 |
| 2014 | 94 | 428 | 72 | 1.04 | $44,475 | $25,128 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Short return visit (20+ min) | 198 | $30,039 | $80 |
| Destruction of precancer skin growth, 1 growth | 123 | $11,860 | $58 |
| Return visit (30+ min) | 49 | $8,702 | $115 |
| Destruction of skin growth, 1-14 growths | 43 | $8,354 | $119 |
| Destruction of precancer skin growth, 2-14 growths | 106 | $6,289 | $7 |
| Biopsy of related skin growth, first growth | 35 | $3,596 | $97 |
| New patient visit (30+ min) | 24 | $2,278 | $95 |
| New patient visit (15+ min) | 29 | $1,869 | $64 |
| Injection of drug or substance under skin or into muscle | 16 | $586 | $14 |
| Pathology examination of tissue using a microscope, intermediate complexity | 14 | $484 | $35 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $44 | None |
2022: 10 services
| Short return visit (20+ min) | 134 | $19,283 | $79 |
| Return visit (30+ min) | 38 | $6,185 | $109 |
| Destruction of precancer skin growth, 1 growth | 68 | $5,364 | $57 |
| New patient visit (30+ min) | 59 | $4,941 | $84 |
| Biopsy of related skin growth, first growth | 33 | $3,244 | $95 |
| Destruction of precancer skin growth, 2-14 growths | 53 | $2,860 | $7 |
| Destruction of skin growth, 1-14 growths | 19 | $2,708 | $104 |
| Injection of drug or substance under skin or into muscle | 18 | $1,096 | $14 |
| Pathology examination of tissue using a microscope, intermediate complexity | 20 | $800 | $33 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $76 | None |
2021: 11 services
| Short return visit (20+ min) | 166 | $32,145 | $83 |
| Return visit (30+ min) | 54 | $9,867 | $106 |
| Destruction of precancer skin growth, 1 growth | 100 | $8,177 | $58 |
| New patient visit (30+ min) | 60 | $5,347 | $89 |
| Biopsy of related skin growth, first growth | 46 | $5,093 | $104 |
| Destruction of precancer skin growth, 2-14 growths | 78 | $4,412 | $7 |
| Destruction of skin growth, 1-14 growths | 19 | $2,962 | $106 |
| Punch biopsy, first skin growth | 17 | $2,606 | $137 |
| Injection of drug or substance under skin or into muscle | 21 | $1,698 | $14 |
| Pathology examination of tissue using a microscope, intermediate complexity | 22 | $895 | $36 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $106 | None |
2020: 11 services
| Return visit (30+ min) | 100 | $16,178 | $99 |
| Short return visit (20+ min) | 114 | $13,547 | $63 |
| Destruction of precancer skin growth, 1 growth | 66 | $4,867 | $51 |
| Biopsy of related skin growth, first growth | 44 | $4,264 | $93 |
| Destruction of skin growth, 1-14 growths | 26 | $3,187 | $103 |
| New patient visit (30+ min) | 34 | $2,680 | $79 |
| Destruction of precancer skin growth, 2-14 growths | 51 | $2,143 | $6 |
| Punch biopsy, first skin growth | 15 | $2,039 | $127 |
| New patient visit (15+ min) | 14 | $1,036 | $74 |
| Injection of drug or substance under skin or into muscle | 17 | $692 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $86 | None |
2019: 9 services
| Short return visit (20+ min) | 122 | $12,555 | $64 |
| Return visit (30+ min) | 83 | $12,297 | $96 |
| Destruction of precancer skin growth, 1 growth | 71 | $5,135 | $52 |
| New patient visit (30+ min) | 47 | $3,982 | $85 |
| Biopsy of related skin growth, first growth | 40 | $3,775 | $90 |
| Destruction of skin growth, 1-14 growths | 14 | $2,202 | $105 |
| Destruction of precancer skin growth, 2-14 growths | 46 | $2,074 | $6 |
| Short return visit | 14 | $920 | $44 |
| Injection into skin growth, 1-7 growths | 13 | $742 | $46 |
2018: 9 services
| Return visit (30+ min) | 99 | $12,871 | $91 |
| Short return visit (20+ min) | 109 | $11,703 | $66 |
| Biopsy of single growth of skin and/or tissue | 70 | $7,493 | $99 |
| New patient visit (30+ min) | 55 | $4,783 | $87 |
| Destruction of precancer skin growth, 1 growth | 62 | $4,692 | $53 |
| Short return visit | 32 | $1,364 | $40 |
| Destruction of precancer skin growth, 2-14 growths | 47 | $1,332 | $5 |
| Pathology examination of tissue using a microscope, intermediate complexity | 16 | $718 | $38 |
| Biopsy of each additional growth of skin and/or tissue | 16 | $708 | $31 |
2017: 6 services
| Return visit (30+ min) | 93 | $11,641 | $97 |
| Short return visit (20+ min) | 67 | $6,502 | $66 |
| New patient visit (30+ min) | 51 | $4,986 | $98 |
| Biopsy of single growth of skin and/or tissue | 34 | $3,994 | $102 |
| Destruction of precancer skin growth, 1 growth | 51 | $3,695 | $56 |
| Destruction of precancer skin growth, 2-14 growths | 40 | $973 | $5 |
2016: 9 services
| Return visit (30+ min) | 69 | $6,702 | $86 |
| Biopsy of single growth of skin and/or tissue | 50 | $4,713 | $83 |
| Short return visit (20+ min) | 54 | $3,704 | $57 |
| Destruction of precancer skin growth, 1 growth | 63 | $3,168 | $46 |
| New patient visit (30+ min) | 34 | $2,734 | $80 |
| Destruction of skin growth, 1-14 growths | 15 | $2,021 | $92 |
| Destruction of precancer skin growth, 2-14 growths | 46 | $998 | $5 |
| New patient visit (15+ min) | 20 | $937 | $47 |
| Short return visit | 11 | $296 | $27 |
2015: 12 services
| Return visit (30+ min) | 110 | $13,920 | $83 |
| Biopsy of single growth of skin and/or tissue | 64 | $6,039 | $79 |
| Destruction of precancer skin growth, 1 growth | 87 | $5,821 | $45 |
| Destruction of skin growth, 1-14 growths | 23 | $3,621 | $91 |
| New patient visit (30+ min) | 33 | $2,707 | $82 |
| Destruction of precancer skin growth, 15 or more growths | 15 | $2,417 | $127 |
| Short return visit (20+ min) | 32 | $2,045 | $57 |
| Destruction of precancer skin growth, 2-14 growths | 66 | $1,937 | $5 |
| New patient visit (15+ min) | 31 | $1,815 | $59 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 13 | $1,625 | $108 |
| Biopsy of each additional growth of skin and/or tissue | 21 | $822 | $28 |
| Short return visit | 13 | $527 | $33 |
2014: 9 services
| Biopsy of single growth of skin and/or tissue | 42 | $3,864 | $82 |
| Return visit (30+ min) | 32 | $3,364 | $89 |
| New patient visit (30+ min) | 24 | $2,198 | $92 |
| Destruction of precancer skin growth, 1 growth | 36 | $2,065 | $48 |
| Short return visit (20+ min) | 23 | $1,730 | $62 |
| New patient visit (15+ min) | 28 | $1,711 | $61 |
| Destruction of precancer skin growth, 2-14 growths | 27 | $1,137 | $9 |
| Destruction of skin growth, 1-14 growths | 11 | $1,014 | $84 |
| Biopsy of each additional growth of skin and/or tissue | 12 | $569 | $28 |
Drugs they prescribed that Part D paid
$226,142
Pharmacies billed $226,142 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 462) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
396 generic and 66 brand-name prescriptions · $226,142 in drug cost · 34 antibiotic prescriptions to 19 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 24 | $97,290 | $4,054 |
| Cosentyx Sensoready (2 Pens) | 12 | $86,953 | $7,246 |
| Clobetasol Propionate | 54 | $3,852 | $71 |
| Tacrolimus | 12 | $1,139 | $95 |
| Mometasone Furoate | 54 | $1,089 | $20 |
See all 16 drugs
| Dupixent | 24 | $97,290 | $4,054 |
| Cosentyx Sensoready (2 Pens) | 12 | $86,953 | $7,246 |
| Clobetasol Propionate | 54 | $3,852 | $71 |
| Tacrolimus | 12 | $1,139 | $95 |
| Mometasone Furoate | 54 | $1,089 | $20 |
| Clindamycin Phosphate | 18 | $898 | $50 |
| Desonide | 32 | $643 | $20 |
| Ketoconazole | 42 | $465 | $11 |
| Cephalexin | 13 | $420 | $32 |
| Minoxidil | 22 | $348 | $16 |
| Triamcinolone Acetonide | 13 | $228 | $18 |
| Minocycline | 18 | $217 | $12 |
| Ciclopirox | 11 | $176 | $16 |
| Hydrocortisone | 25 | $162 | $6 |
| Ciclopirox | 12 | $92 | $8 |
| Mupirocin | 14 | $82 | $6 |
Year by year
| 2024 | 462 | 156 | 0% (0) | 14% | $226,142 |
| 2023 | 430 | 157 | 0% (0) | None | $174,116 |
| 2022 | 335 | 112 | 0% (0) | None | $163,855 |
| 2021 | 407 | 150 | 0% (0) | 15% | $167,118 |
| 2020 | 292 | 108 | None | 11% | $53,375 |
| 2019 | 261 | 114 | None | 16% | $42,922 |
| 2018 | 304 | 132 | 0% (0) | 9% | $12,464 |
| 2017 | 214 | 95 | 0% (0) | 16% | $63,457 |
| 2016 | 328 | 158 | 0% (0) | 15% | $16,388 |
| 2015 | 295 | 145 | 0% (0) | 16% | $14,511 |
| 2014 | 247 | 113 | 0% (0) | 22% | $15,492 |
| 2013 | 310 | 143 | 0% (0) | None | $36,212 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Dupixent | 26 | $97,410 | $3,747 |
| Clobetasol Propionate | 55 | $4,076 | $74 |
| Betamethasone Dipropionate | 19 | $1,627 | $86 |
| Tacrolimus | 12 | $1,314 | $109 |
| Desonide | 37 | $1,009 | $27 |
| Ciclopirox | 18 | $1,009 | $56 |
| Mometasone Furoate | 43 | $912 | $21 |
| Clindamycin Phosphate | 12 | $555 | $46 |
| Ketoconazole | 25 | $513 | $21 |
| Triamcinolone Acetonide | 24 | $451 | $19 |
| Ciclopirox | 14 | $220 | $16 |
| Minocycline | 12 | $205 | $17 |
| Hydrocortisone | 20 | $186 | $9 |
| Mupirocin | 16 | $141 | $9 |
2022: 12 drugs
| Dupixent | 24 | $84,197 | $3,508 |
| Cosentyx Pen (2 Pens) | 11 | $69,062 | $6,278 |
| Clobetasol Propionate | 21 | $1,275 | $61 |
| Fluocinonide | 14 | $882 | $63 |
| Mometasone Furoate | 49 | $843 | $17 |
| Triamcinolone Acetonide | 24 | $577 | $24 |
| Ciclopirox | 12 | $542 | $45 |
| Desonide | 29 | $487 | $17 |
| Ketoconazole | 18 | $435 | $24 |
| Minocycline | 14 | $272 | $19 |
| Hydrocortisone | 18 | $167 | $9 |
| Mupirocin | 13 | $103 | $8 |
2021: 13 drugs
| Dupixent | 24 | $78,348 | $3,264 |
| Cosentyx Pen (2 Pens) | 13 | $76,819 | $5,909 |
| Clobetasol Propionate | 31 | $1,527 | $49 |
| Triamcinolone Acetonide | 72 | $1,290 | $18 |
| Ketoconazole | 41 | $852 | $21 |
| Fluocinonide | 13 | $631 | $49 |
| Desonide | 25 | $497 | $20 |
| Mometasone Furoate | 16 | $355 | $22 |
| Minocycline | 18 | $339 | $19 |
| Ammonium Lactate | 20 | $325 | $16 |
| Mupirocin | 27 | $261 | $10 |
| Hydrocortisone | 16 | $108 | $7 |
| Cephalexin | 17 | $105 | $6 |
2020: 11 drugs
| Dupixent | 11 | $35,626 | $3,239 |
| Triamcinolone Acetonide | 79 | $1,171 | $15 |
| Halobetasol Propionate | 12 | $1,168 | $97 |
| Clobetasol Propionate | 23 | $1,021 | $44 |
| Fluocinonide | 11 | $595 | $54 |
| Desonide | 14 | $447 | $32 |
| Minocycline | 21 | $439 | $21 |
| Ciclopirox | 14 | $370 | $26 |
| Ketoconazole | 12 | $226 | $19 |
| Mupirocin | 18 | $178 | $10 |
| Cephalexin | 15 | $92 | $6 |
2019: 7 drugs
| Clobetasol Propionate | 28 | $3,160 | $113 |
| Triamcinolone Acetonide | 51 | $701 | $14 |
| Ketoconazole | 19 | $587 | $31 |
| Desonide | 12 | $569 | $47 |
| Minocycline | 23 | $560 | $24 |
| Mometasone Furoate | 11 | $285 | $26 |
| Cephalexin | 27 | $175 | $6 |
2018: 10 drugs
| Triamcinolone Acetonide | 76 | $1,203 | $16 |
| Doxycycline Monohydrate | 15 | $1,007 | $67 |
| Clobetasol Propionate | 14 | $956 | $68 |
| Ketoconazole | 20 | $825 | $41 |
| Minocycline | 13 | $467 | $36 |
| Desonide | 12 | $342 | $28 |
| Valacyclovir | 11 | $305 | $28 |
| Mupirocin | 22 | $205 | $9 |
| Cephalexin | 18 | $124 | $7 |
| Hydrocortisone | 12 | $89 | $7 |
2017: 8 drugs
| Triamcinolone Acetonide | 52 | $852 | $16 |
| Desonide | 14 | $719 | $51 |
| Betamethasone Valerate | 11 | $560 | $51 |
| Ketoconazole | 14 | $463 | $33 |
| Valacyclovir | 17 | $210 | $12 |
| Mupirocin | 11 | $125 | $11 |
| Prednisone | 13 | $60 | $5 |
| Cephalexin | 11 | $48 | $4 |
2016: 10 drugs
| Clobetasol Propionate | 14 | $2,082 | $149 |
| Betamethasone Valerate | 22 | $1,444 | $66 |
| Ciclopirox | 25 | $1,097 | $44 |
| Ketoconazole | 50 | $1,007 | $20 |
| Triamcinolone Acetonide | 70 | $948 | $14 |
| Ammonium Lactate | 23 | $755 | $33 |
| Doxycycline Monohydrate | 11 | $377 | $34 |
| Mupirocin | 15 | $159 | $11 |
| Hydrocortisone | 17 | $142 | $8 |
| Cephalexin | 14 | $103 | $7 |
2015: 7 drugs
| Ammonium Lactate | 34 | $866 | $25 |
| Triamcinolone Acetonide | 62 | $856 | $14 |
| Doxycycline Monohydrate | 12 | $664 | $55 |
| Desonide | 14 | $629 | $45 |
| Ketoconazole | 40 | $625 | $16 |
| Hydrocortisone | 17 | $126 | $7 |
| Cephalexin | 14 | $74 | $5 |
2014: 6 drugs
| Clobetasol Propionate | 21 | $1,114 | $53 |
| Betamethasone Valerate | 24 | $824 | $34 |
| Desonide | 11 | $588 | $53 |
| Triamcinolone Acetonide | 25 | $477 | $19 |
| Ketoconazole | 26 | $378 | $15 |
| Selenium Sulfide | 15 | $156 | $10 |
2013: 9 drugs
| Doxycycline Hyclate | 25 | $3,410 | $136 |
| Metronidazole | 11 | $1,251 | $114 |
| Betamethasone Valerate | 25 | $1,160 | $46 |
| Fluocinonide | 24 | $1,018 | $42 |
| Clobetasol Propionate | 25 | $729 | $29 |
| Triamcinolone Acetonide | 26 | $590 | $23 |
| Ketoconazole | 27 | $500 | $19 |
| Mupirocin | 11 | $169 | $15 |
| Selenium Sulfide | 11 | $127 | $12 |
Money from drug and device companies
$2,278 in 2025
| 2025 | 20 | 113 | None | $2,278 |
| 2024 | 23 | 151 | None | $3,135 |
| 2023 | 17 | 108 | None | $2,509 |
| 2022 | 15 | 77 | None | $1,680 |
| 2021 | 15 | 60 | None | $1,207 |
| 2020 | 18 | 57 | None | $1,095 |
| 2019 | 18 | 61 | None | $1,096 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $392 | 22 payments
|
| Regeneron Healthcare Solutions | Dupixent | $277 | 13 payments
|
| LEO Pharma | Adbry | $216 | 10 payments
|
| Incyte | Opzelura | $208 | 11 payments
|
| Genzyme | Dupixent | $163 | 6 payments
|
| Ucb | Bimzelx | $163 | 12 payments
|
See all 113 published payments
| Regeneron Healthcare Solutions | Meals · 2025-12-18 | Dupixent | $23 |
| Abbvie | Meals · 2025-12-16 | Skyrizi | $7 |
| Ucb | Meals · 2025-12-16 | Bimzelx | $15 |
| LEO Pharma | Meals · 2025-12-15 | Anzupgo | $26 |
| Janssen Biotech | Meals · 2025-12-09 | Tremfya | $21 |
| Abbvie | Meals · 2025-12-08 | Rinvoq | $23 |
| Amgen | Meals · 2025-12-08 | Otezla | $28 |
| Incyte | Meals · 2025-12-05 | Opzelura | $1 |
| Incyte | Meals · 2025-12-05 | Opzelura | $11 |
| Arcutis Biotherapeutics | Meals · 2025-12-04 | Zoryve | $14 |
| LEO Pharma | Meals · 2025-12-02 | Adbry | $29 |
| LEO Pharma | Meals · 2025-12-02 | Adbry | $29 |
| LEO Pharma | Meals · 2025-11-26 | Adbry | $13 |
| Galderma Laboratories L.P. | Meals · 2025-11-20 | Nemluvio | $25 |
| Incyte | Meals · 2025-11-19 | Opzelura | $29 |
| Abbvie | Meals · 2025-11-18 | Skyrizi | $11 |
| Ucb | Meals · 2025-11-06 | Bimzelx | $16 |
| Sun Pharmaceutical Industries | Meals · 2025-11-06 | Ilumya | $33 |
| LEO Pharma | Meals · 2025-11-06 | Adbry | $9 |
| Organon | Meals · 2025-11-03 | Vtama | $15 |
| Abbvie | Meals · 2025-10-30 | Rinvoq | $28 |
| Incyte | Meals · 2025-10-28 | Opzelura | $5 |
| Genzyme | Meals · 2025-10-28 | Dupixent | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-10-24 | Dupixent | $19 |
| Ucb | Meals · 2025-10-21 | Bimzelx | $16 |
| LEO Pharma | Meals · 2025-10-14 | Adbry | $28 |
| Mallinckrodt Hospital Products | Meals · 2025-10-07 | Acthar | $34 |
| Regeneron Healthcare Solutions | Meals · 2025-10-07 | Dupixent | $20 |
| Incyte | Meals · 2025-10-07 | Opzelura | $28 |
| Lilly USA | Meals · 2025-10-06 | Taltz | $30 |
| Abbvie | Meals · 2025-10-03 | Skyrizi | $9 |
| Verrica Pharmaceuticals | Meals · 2025-10-03 | Ycanth | $23 |
| Organon | Meals · 2025-10-02 | Vtama | $15 |
| Janssen Biotech | Meals · 2025-09-30 | Tremfya | $29 |
| Ucb | Meals · 2025-09-30 | Bimzelx | $16 |
| Incyte | Meals · 2025-09-30 | Opzelura | $10 |
| Lilly USA | Meals · 2025-09-25 | Taltz | $23 |
| LEO Pharma | Meals · 2025-09-25 | Adbry | $17 |
| Abbvie | Meals · 2025-09-20 | Botox | $6 |
| Revance Therapeutics | Meals · 2025-09-20 | Daxi | $25 |
| LEO Pharma | Meals · 2025-09-18 | Anzupgo | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-09-06 | Dupixent | $26 |
| Incyte | Meals · 2025-09-05 | Opzelura | $23 |
| Ucb | Meals · 2025-09-04 | Bimzelx | $13 |
| Janssen Biotech | Meals · 2025-08-28 | Tremfya | $0 |
| Janssen Biotech | Meals · 2025-08-28 | Tremfya | $31 |
| Lilly USA | Meals · 2025-08-25 | Taltz | $30 |
| Abbvie | Meals · 2025-08-22 | Rinvoq | $16 |
| Abbvie | Meals · 2025-08-22 | Rinvoq | $9 |
| MIMEDX Group | Meals · 2025-08-08 | None | $30 |
| Arcutis Biotherapeutics | Meals · 2025-08-05 | Zoryve | $17 |
| Merz North America | Meals · 2025-07-28 | None | $44 |
| Genzyme | Meals · 2025-07-22 | Dupixent | $30 |
| Abbvie | Meals · 2025-07-21 | Rinvoq | $28 |
| Novartis Pharmaceuticals | Meals · 2025-07-17 | Cosentyx | $14 |
| Abbvie | Meals · 2025-07-17 | Rinvoq | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-07-16 | Dupixent | $22 |
| Janssen Biotech | Meals · 2025-07-14 | Tremfya | $6 |
| Janssen Biotech | Meals · 2025-07-14 | Tremfya | $6 |
| Ucb | Meals · 2025-07-08 | Bimzelx | $14 |
| Abbvie | Meals · 2025-07-02 | Skyrizi | $15 |
| Incyte | Meals · 2025-06-27 | Opzelura | $29 |
| Incyte | Meals · 2025-06-24 | Opzelura | $20 |
| Ucb | Meals · 2025-06-17 | Bimzelx | $11 |
| Pfizer | Meals · 2025-06-10 | Cibinqo | $27 |
| Janssen Biotech | Meals · 2025-06-09 | Tremfya | $6 |
| Janssen Biotech | Meals · 2025-06-09 | Tremfya | $2 |
| Janssen Biotech | Meals · 2025-06-09 | Tremfya | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-06-06 | Dupixent | $18 |
| Incyte | Meals · 2025-06-06 | Opzelura | $26 |
| Ucb | Meals · 2025-05-29 | Bimzelx | $17 |
| Genzyme | Meals · 2025-05-27 | Dupixent | $25 |
| Lilly USA | Meals · 2025-05-22 | Ebglyss | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-05-21 | Dupixent | $13 |
| Novartis Pharmaceuticals | Meals · 2025-05-19 | Cosentyx | $15 |
| Abbvie | Meals · 2025-05-14 | Rinvoq | $12 |
| Abbvie | Meals · 2025-05-14 | Rinvoq | $13 |
| Regeneron Healthcare Solutions | Meals · 2025-05-07 | Dupixent | $25 |
| LEO Pharma | Meals · 2025-05-01 | Adbry | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-04-23 | Dupixent | $25 |
| Incyte | Meals · 2025-04-21 | Opzelura | $26 |
| Genzyme | Meals · 2025-04-15 | Dupixent | $22 |
| MIMEDX Group | Meals · 2025-04-15 | None | $34 |
| Ucb | Meals · 2025-04-03 | Bimzelx | $9 |
| Abbvie | Meals · 2025-03-26 | Rinvoq | $31 |
| Abbvie | Meals · 2025-03-26 | Skyrizi | $25 |
| Regeneron Healthcare Solutions | Meals · 2025-03-26 | Dupixent | $25 |
| MIMEDX Group | Meals · 2025-03-26 | None | $40 |
| Abbvie | Meals · 2025-03-18 | Skyrizi | $28 |
| Genzyme | Meals · 2025-03-18 | Dupixent | $26 |
| Arcutis Biotherapeutics | Meals · 2025-03-14 | Zoryve | $26 |
| Abbvie | Meals · 2025-03-11 | Rinvoq | $24 |
| Pfizer | Meals · 2025-03-11 | Cibinqo | $16 |
| Lilly USA | Meals · 2025-03-10 | Taltz | $24 |
| Novartis Pharmaceuticals | Meals · 2025-03-06 | Cosentyx | $21 |
| Janssen Biotech | Meals · 2025-03-04 | Tremfya | $27 |
| Abbvie | Meals · 2025-02-28 | Rinvoq | $31 |
| Novartis Pharmaceuticals | Meals · 2025-02-26 | Cosentyx | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-02-26 | Libtayo | $12 |
| Regeneron Healthcare Solutions | Meals · 2025-02-25 | Dupixent | $20 |
| Abbvie | Meals · 2025-02-08 | Rinvoq | $27 |
| LEO Pharma | Meals · 2025-02-04 | Adbry | $28 |
| Ucb | Meals · 2025-01-30 | Bimzelx | $14 |
| Arcutis Biotherapeutics | Meals · 2025-01-28 | Zoryve | $18 |
| Organon | Meals · 2025-01-22 | Vtama | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-01-17 | Dupixent | $28 |
| Ucb | Meals · 2025-01-16 | Bimzelx | $17 |
| Genzyme | Meals · 2025-01-14 | Dupixent | $32 |
| Ucb | Meals · 2025-01-13 | Bimzelx | $6 |
| Abbvie | Meals · 2025-01-09 | Rinvoq | $9 |
| Abbvie | Meals · 2025-01-09 | Rinvoq | $10 |
| Abbvie | Meals · 2025-01-09 | Rinvoq | $4 |
| Janssen Biotech | Meals · 2025-01-07 | Tremfya | $27 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,135
| Abbvie | Skyrizi | $643 | 31 payments
|
| Regeneron Healthcare Solutions | Dupixent | $299 | 14 payments
|
| Genzyme | Dupixent | $250 | 10 payments
|
| Lilly USA | Taltz | $232 | 8 payments
|
| Novartis Pharmaceuticals | Cosentyx | $210 | 13 payments
|
| Janssen Biotech | Tremfya | $180 | 16 payments
|
| Ucb | Bimzelx | $180 | 10 payments
|
| Incyte | Opzelura | $169 | 13 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $123 | 4 payments
|
| Galderma Laboratories L.P. | Aklief | $116 | 4 payments
|
| Dermavant Sciences | Vtama | $109 | 4 payments
|
| LEO Pharma | Adbry | $87 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $85 | 3 payments
|
| Sun Pharmaceutical Industries | Ilumya | $84 | 3 payments
|
| Arcutis Biotherapeutics | Zoryve | $68 | 3 payments
|
| Amgen | Otezla | $62 | 2 payments
|
| Revance Therapeutics | Daxxify | $53 | 2 payments
|
| STRATA Skin Sciences | Xtrac | $49 | 2 payments
|
| Organogenesis | Puraply Am | $44 | 1 payment
|
| Fresenius Kabi USA | Idacio | $29 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Cabtreo | $25 | 1 payment
|
| Merz North America | None | $22 | 1 payment
|
| Pfizer | Cibinqo | $19 | 1 payment
|
2023: $2,509
| AbbVie | Skyrizi | $485 | 24 payments
|
| Genzyme | Dupixent | $320 | 13 payments
|
| Regeneron Healthcare Solutions | Dupixent | $313 | 10 payments
|
| Lilly USA | Taltz | $292 | 11 payments
|
| Pfizer | Eucrisa | $204 | 10 payments
|
| Ucb | Cimzia | $143 | 7 payments
|
| LEO Pharma | Adbry | $122 | 5 payments
|
| Novartis Pharmaceuticals | Cosentyx | $113 | 6 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $96 | 4 payments
|
| Arcutis Biotherapeutics | None | $95 | 4 payments
|
| Sun Pharmaceutical Industries | Winlevi | $86 | 3 payments
|
| Dermavant Sciences | Vtama | $70 | 3 payments
|
| Incyte | Opzelura | $56 | 3 payments
|
| Ortho Dermatologics a division of Bausch Health US | Arazlo | $32 | 2 payments
|
| Fresenius Kabi USA | Idacio | $31 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $29 | 1 payment
|
| Janssen Biotech | Remicade | $21 | 1 payment
|
2022: $1,680
| Abbvie | Skyrizi | $455 | 20 payments
|
| Regeneron Healthcare Solutions | Dupixent | $257 | 13 payments
|
| Novartis Pharmaceuticals | Cosentyx | $175 | 12 payments
|
| Janssen Biotech | Tremfya | $161 | 6 payments
|
| Pfizer | Cibinqo | $119 | 5 payments
|
| Lilly USA | Taltz | $92 | 4 payments
|
| Sun Pharmaceutical Industries | Ilumya | $91 | 3 payments
|
| Ucb | Cimzia | $90 | 3 payments
|
| Genzyme | Dupixent | $55 | 2 payments
|
| Incyte | Opzelura | $53 | 2 payments
|
| Galderma Laboratories L.P. | Epsolay | $38 | 2 payments
|
| Journey Medical | Qbrexza | $33 | 2 payments
|
| Allergan | Botox | $29 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $18 | 1 payment
|
| LEO Pharma | Adbry | $13 | 1 payment
|
2021: $1,207
| AbbVie | Skyrizi | $245 | 11 payments
|
| Regeneron Healthcare Solutions | Dupixent | $201 | 8 payments
|
| Novartis Pharmaceuticals | Cosentyx | $191 | 13 payments
|
| Genzyme | Dupixent | $121 | 5 payments
|
| Lilly USA | Taltz | $79 | 4 payments
|
| LEO Pharma | Enstilar | $60 | 3 payments
|
| Galderma Laboratories L.P. | Aklief | $56 | 3 payments
|
| Almirall | Seysara | $55 | 3 payments
|
| Janssen Biotech | Remicade | $46 | 3 payments
|
| Organogenesis | Puraply Antimicrobial | $39 | 1 payment
|
| Ucb | Cimzia | $35 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $25 | 1 payment
|
| Sun Pharmaceutical Industries | Absorica Ld | $24 | 1 payment
|
| Allergan | None | $17 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $12 | 1 payment
|
2020: $1,095
| Galderma Laboratories L.P. | Soolantra | $175 | 10 payments
|
| Mayne Pharma | Doryx | $172 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $129 | 6 payments
|
| Janssen Biotech | Tremfya | $111 | 7 payments
|
| Pfizer | Eucrisa | $71 | 4 payments
|
| Novartis Pharmaceuticals | Cosentyx | $66 | 4 payments
|
| AbbVie | Skyrizi | $62 | 3 payments
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $59 | 3 payments
|
| Lilly USA | Taltz | $46 | 2 payments
|
| LEO Pharma | Enstilar | $38 | 2 payments
|
| Dermira | Qbrexza | $34 | 2 payments
|
| Amgen | Otezla | $27 | 1 payment
|
| Biofrontera | Ameluz | $22 | 1 payment
|
| Ucb | Cimzia | $21 | 1 payment
|
| VYNE Pharmaceuticals | Amzeeq | $20 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $15 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $13 | 1 payment
|
| EPI Health | Sitavig | $12 | 1 payment
|
2019: $1,096
| Novartis Pharmaceuticals | Cosentyx | $190 | 12 payments
|
| Janssen Biotech | Tremfya | $118 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $111 | 6 payments
|
| AbbVie | Humira | $108 | 6 payments
|
| Sun Pharmaceutical Industries | Ilumya | $85 | 5 payments
|
| Aclaris Therapeutics | Eskata | $67 | 3 payments
|
| Almirall | Seysara | $61 | 3 payments
|
| Galderma Laboratories L.P. | Epiduo Forte | $60 | 4 payments
|
| Ucb | Cimzia | $54 | 3 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $50 | 3 payments
|
| Allergan | Botox Cosmetic | $39 | 2 payments
|
| Journey Medical | Exelderm | $32 | 2 payments
|
| Solta Medical a division of Bausch Health US | None | $24 | 1 payment
|
| Genentech USA | Erivedge | $24 | 1 payment
|
| Mayne Pharma | Doryx | $23 | 1 payment
|
| Amgen | Otezla | $18 | 1 payment
|
| LEO Pharma | Enstilar | $16 | 1 payment
|
| Merck Sharp & Dohme | Sivextro | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 98.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1386960847
- Licence
- CA A141215, FL ME 117991California A141215: Current · expires 2027-07-31Florida ME117991: Null And Void
- Trained
- Jefferson Medical College of Thomas Jefferson University, 2010
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Federal specialty code 174400000X (174400000X)
- Mailing address
- 2490 Hospital Dr Ste 201, Mountain View, CA, 94040
- NPI first listed
- 2010-04-08
- NPI last updated
- 2019-01-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 7400 N Kendall Dr, Miami, FL, 33156